Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00003647

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Comprehensive Blood and Cancer Center Bakersfield, California, United States

Scripps Memorial Hospitals-Stevens Cancer Center - Encinitas Encinitas, California, United States

Kaiser Permanente-Southern California Permanente Medical Group San Diego, California, United States

View all 44 locations

View Trial Details

Completed

Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL Clones

NCT00720031

Conditions: Immunotherapy, Melanoma, Neoplasms, +10 more
Locations: Nantes University Hopspital Nantes, Pays de la Loire Region, France

View Trial Details

Completed

Sentinel Node With Ultrasound Contrast in Melanoma

NCT00370136

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Copenhagen univercity hospital, Department of Radiology, section of ultrasound Copenhagen, Denmark

View Trial Details

Completed

Diagnosis and Treatment of Pheochromocytoma

NCT00001229

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

NCT00001705

Conditions: Melanoma, Neoplasm Metastasis, Neoplasms, +13 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

NCT00001296

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity

NCT00001577

Conditions: Body Temperature Changes, Heat Stress Disorders, Hyperthermia, +17 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

NCT00075166

Conditions: Brain Diseases, Brain Neoplasms, Carcinoma, +21 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Completed

Analysis of NF2 Mutations in Radiation-Related Neural Tumors

NCT00340496

Conditions: Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +14 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

Blood Sampling for Neurochemical and Genetic Testing

NCT00001147

Conditions: Autonomic Nervous System Disease, Cardiovascular Diseases, Healthy, +10 more
Locations: National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions